Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

By sjmartinez • January 10, 2025

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2024 Dec 24;79:101196. doi: 10.1016/j.drup.2024.101196. Epub ahead of print. PMID: 39787991.

Tags: breast cancer, Dephosphorylation, FOXO3a, General Internal Medicine, King Drew Med Ctr, Post Doc, Publications, TRAIL, Wip1

Zero-shot medical event prediction using a generative pretrained transformer on electronic health records

Redekop E, Wang Z, Kulkarni R, Pleasure M, Chin A, Hassanzadeh HR, Hill BL, Emami M, Speier WF, Arnold CW. Zero-shot medical event prediction using[...]

Federal Housing Assistance and Stage at Cancer Diagnosis Among Older Adults in the US

Pollack CE, Blackford AL, Craig TK, Fan Q, Hussaini SMQ, Chen KL, Polsky D, Katana Ogongo M, Warren JL, Gross CP, Yabroff KR. Federal Housing[...]

Bridging gaps throughout a patient’s journey with melanoma: a systematic review

Amarsi A, Xu J, Chan J, Jiang YC, Omar AZ, Meghdadi Y, Doshi A, Xie A, Wu A. Bridging gaps throughout a patient's journey with[...]